Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis in prior interferon users with low clinical disease activity: Integrated analysis of the phase 3 DEFINE and CONFIRM studies

Authors
Category Primary study
ConferenceMultiple Sclerosis
Year 2015
This article has no abstract
Epistemonikos ID: 5ab4ad753e991ba74377930852eb58516351a320
First added on: Apr 30, 2026